Testosterone and "Low T"
Episode
56 min
Read time
2 min
Topics
Health & Wellness, Investing, Fundraising & VC
AI-Generated Summary
Key Takeaways
- ✓Marketing Disease Creation: Pharmaceutical company Solvay invented "Low T" in 2000 to expand Androgel's market beyond rare hypogonadism cases. They sponsored the ADAM questionnaire (drafted in 20 minutes), funded studies showing 40% of men over 45 had "low testosterone," and ran awareness campaigns generating $1.3 billion in 2012 sales while avoiding FDA restrictions by not naming the drug directly.
- ✓Normal Range Manipulation: Testosterone levels between 250-800 nanograms per deciliter qualify as normal, varying dramatically by age, time of day, and recent experiences. The "winner effect" shows testosterone rises 15-35% after success (sports wins, work achievements) and drops similarly after losses. This natural fluctuation means men can test "low" one day and normal days later, enabling easy diagnosis.
- ✓Limited Clinical Benefits: A 2016 New England Journal of Medicine trial with 790 men over 65 found testosterone replacement produced moderate improvements in sexual function and mood but showed no benefits for vitality, energy levels, or walking distance. The study contradicted marketing promises of comprehensive life transformation, revealing TRT addresses only narrow symptom categories in older men.
- ✓Telehealth Expansion Risks: Online men's health companies (Hims, Hone, Maximus) now provide TRT prescriptions within 30 minutes via cash-only assessments without comprehensive medical evaluation. This bypasses proper diagnosis of underlying conditions like depression or obesity that may cause low testosterone as a symptom rather than root cause, treating numbers instead of actual health problems.
- ✓Permanent Physiological Changes: Taking exogenous testosterone causes testicles to atrophy since the body stops producing its own supply. Some men cannot restart natural production after stopping TRT, requiring lifelong treatment. The therapy also amplifies aggression, reduces empathy and patience, and eliminates mental space previously occupied by sexual thoughts, fundamentally altering personality and social functioning beyond physical effects.
What It Covers
This episode examines how testosterone replacement therapy transformed from rare medical treatment for serious testicular dysfunction into a mainstream lifestyle intervention used by 14% of men over 40. It traces pharmaceutical marketing that rebranded normal aging as "Low T," creating a billion-dollar industry despite limited evidence of benefits beyond sexual function and mood.
Key Questions Answered
- •Marketing Disease Creation: Pharmaceutical company Solvay invented "Low T" in 2000 to expand Androgel's market beyond rare hypogonadism cases. They sponsored the ADAM questionnaire (drafted in 20 minutes), funded studies showing 40% of men over 45 had "low testosterone," and ran awareness campaigns generating $1.3 billion in 2012 sales while avoiding FDA restrictions by not naming the drug directly.
- •Normal Range Manipulation: Testosterone levels between 250-800 nanograms per deciliter qualify as normal, varying dramatically by age, time of day, and recent experiences. The "winner effect" shows testosterone rises 15-35% after success (sports wins, work achievements) and drops similarly after losses. This natural fluctuation means men can test "low" one day and normal days later, enabling easy diagnosis.
- •Limited Clinical Benefits: A 2016 New England Journal of Medicine trial with 790 men over 65 found testosterone replacement produced moderate improvements in sexual function and mood but showed no benefits for vitality, energy levels, or walking distance. The study contradicted marketing promises of comprehensive life transformation, revealing TRT addresses only narrow symptom categories in older men.
- •Telehealth Expansion Risks: Online men's health companies (Hims, Hone, Maximus) now provide TRT prescriptions within 30 minutes via cash-only assessments without comprehensive medical evaluation. This bypasses proper diagnosis of underlying conditions like depression or obesity that may cause low testosterone as a symptom rather than root cause, treating numbers instead of actual health problems.
- •Permanent Physiological Changes: Taking exogenous testosterone causes testicles to atrophy since the body stops producing its own supply. Some men cannot restart natural production after stopping TRT, requiring lifelong treatment. The therapy also amplifies aggression, reduces empathy and patience, and eliminates mental space previously occupied by sexual thoughts, fundamentally altering personality and social functioning beyond physical effects.
Notable Moment
A 1994 World Cup study measured testosterone in Brazilian and Italian soccer fans immediately after Brazil won the final match. Eleven of twelve Brazilian fans showed testosterone increases of 15-35% within minutes, with two experiencing 100% spikes. Every Italian fan experienced drops of similar magnitude, with two losing over 50% of their testosterone purely from watching their team lose.
Episode Transcript
I always knew that there was a problem, but every time I would go to a doctor, they wouldn't actually tell me that I had an issue. This is Drew. I'm 38 years old currently. I live in Brooklyn, New York. Drew felt that something was wrong, but he didn't know what until the Internet gave him a hint. Maybe this wasn't a mental issue. Maybe it was his testosterone. So Drew made an appointment with his doctor. And he ran the test, and my numbers were in the low two hundreds. But for some reason, he told me that that was fine. I don't need my numbers to be any higher, so he kinda gave me the runaround on that. But I know as a man, you know, that the way I was feeling, it it wasn't I I wasn't a 100% there. Right. So I didn't take his his word for it at all because I knew that there was a bigger issue underlying that he wasn't helping me with. Yeah. Yeah. It sounds like he wasn't very sympathetic. Not not at all. Drew was struggling, and he knew that his testosterone level was relatively low for a man in his mid thirties. So he started doing his own research on Reddit. There's a lot of talk about testosterone on Reddit. There's a whole subreddit called, well, testosterone, with 200,000 members mostly talking about testosterone replacement therapy or TRT. Reddit kinda gave me more of the information that I was looking for because, like you said, in the real world and real people actually giving you real advice or or their situations. Eventually, Drew decided that TRT was right for him too. So he found a men's clinic in his neighborhood in Brooklyn and scheduled a visit. Do you remember your first shot? Yeah. I do remember. And it's it's kind of funny because when I as soon as I got the shot, I and I know for a fact this is a placebo effect, but my confidence boost was like sky high. I was walking around like, I felt like the man everywhere I went. And I know for a fact that it was the placebo, but I think it was it was like a new beginning for me. I was fixing something that I had a problem with for a long time, and it felt good to know I'm dealing with it. Yeah. Yeah. So, yeah, that first shot was, like mentally, it was the best the best feeling that I've had. Drew kept going back every two weeks for his dose. And in a few weeks, he started to feel the effect for real this time. And as the weeks progressed, I started just getting emotionally, like, more confident. My self esteem would boost up. And that's when I knew something was happening because before I would have to fight for those feelings. This time it was I was just waking up with confidence and …
Get the full transcript (8,625 words) + summary by email — free
One-time email with the complete transcript and AI summary of this episode. No account needed.
One email, no spam. We’ll also show you what SignalCast does.
You just read a 3-minute summary of a 53-minute episode.
Get Drug Story summarized like this every Monday — plus up to 2 more podcasts, free.
Pick Your Podcasts — FreeKeep Reading
More from Drug Story
Bonus Episode: Thomas talks with STAT
Apr 29 · 30 min
The Mel Robbins Podcast
The Ultimate Guide to Women’s Sexual Health, Hormone Replacement Therapy (HRT) & Menopause
Mar 23
More from Drug Story
On fluoride and tooth decay
Mar 31 · 50 min
Eye on AI
#317 Steven Brown: Why Modern Medicine Needs AI-Assisted Decision Making
Jan 25
Books, tools, and gear mentioned in this episode
SignalCast may earn commission on purchases via these links.
Tools
by Solvay
“Pharmaceutical company Solvay invented "Low T" in 2000 to expand Androgel's market beyond rare hypogonadism cases.”
“Online men's health companies (Hims, Hone, Maximus) now provide TRT prescriptions within 30 minutes via cash-only assessments.”
“Online men's health companies (Hims, Hone, Maximus) now provide TRT prescriptions within 30 minutes via cash-only assessments.”
“Online men's health companies (Hims, Hone, Maximus) now provide TRT prescriptions within 30 minutes via cash-only assessments.”
“Sponsors section lists GoodRx as a sponsor of the episode.”
other
“They sponsored the ADAM questionnaire (drafted in 20 minutes), funded studies showing 40% of men over 45 had "low testosterone."”
More from Drug Story
We summarize every new episode. Want them in your inbox?
Similar Episodes
Related episodes from other podcasts
The Mel Robbins Podcast
Mar 23
The Ultimate Guide to Women’s Sexual Health, Hormone Replacement Therapy (HRT) & Menopause
Eye on AI
Jan 25
#317 Steven Brown: Why Modern Medicine Needs AI-Assisted Decision Making
The Genius Life
Jan 19
543: The New Rules of Men’s Health, Aging, and Performance | Josh Duhamel
The Peter Attia Drive
Dec 1
#374 - The evolutionary biology of testosterone: how it shapes male development and sex-based behavioral differences, | Carole Hooven, Ph.D.
The RTW Podcast
Oct 6
14 Months to Treatment: Breaking Records in Rare Disease Therapy
Explore Related Topics
This podcast is featured in Best Health Podcasts (2026) — ranked and reviewed with AI summaries.
Read this week's Health & Longevity Podcast Insights — cross-podcast analysis updated weekly.
You're clearly into Drug Story.
Every Monday, we deliver AI summaries of the latest episodes from Drug Story and 192+ other podcasts. Free for one show.
Start My Monday DigestNo credit card · Unsubscribe anytime